CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	May 31, 2025	May 31, 2024
Operating Activities:
Net income	$ 116,346	$ 109,807
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	65,386	61,114
Allowance for credit losses	0	(5)
Loss on sale of property and equipment	1,579	872
Deferred income taxes	(953)	461
Equity in losses (gains) of unconsolidated affiliates	13	(82)
Stock-based compensation	13,806	12,652
Change in operating assets and liabilities:
Receivables, prepaid expenses and other current assets, non-current assets, accrued salaries and benefits, deferred membership income and other accruals	(9,329)	(12,998)
Merchandise inventories	(24,445)	(45,057)
Accounts payable	16,757	38,990
Net cash provided by operating activities	179,160	165,754
Investing Activities:
Additions to property and equipment	(101,586)	(141,873)
Purchases of short-term investments	(72,255)	(134,108)
Proceeds from settlements of short-term investments	77,818	125,464
Proceeds from disposal of property and equipment	235	1,138
Net cash used in investing activities	(95,788)	(149,379)
Financing Activities:
Proceeds from long-term bank borrowings	5,441	16,500
Repayment of long-term bank borrowings	(32,742)	(21,433)
Proceeds from short-term bank borrowings	10,964	3,884
Repayment of short-term bank borrowings	(318)	(2,941)
Cash dividend payments	(19,376)	(48,437)
Purchase of treasury stock	(5,857)	(71,852)
Net cash used in financing activities	(41,888)	(124,279)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	5,324	(3,956)
Net increase (decrease) in cash, cash equivalents	46,808	(111,860)
Cash, cash equivalents and restricted cash at beginning of period	136,311	252,202
Cash, cash equivalents and restricted cash at end of period	183,119	140,342
Supplemental disclosure of noncash investing activities:
Capital expenditures accrued, but not yet paid	1,140	3,514
Dividends declared but not yet paid	19,411	17,771
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents	167,961	128,271
Short-term restricted cash	3,488	2,832
Long-term restricted cash	11,670	9,239
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	$ 183,119	$ 140,342